PROCEPT BioRobotics (PRCT) Financial Analysis & Valuation | Quarter Chart
PROCEPT BioRobotics (PRCT)
PRCTPrice: $26.46
Fair Value: 🔒
🔒score
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic ... more
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in u... more
Description
Shares
| Market Cap | $1.51B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Larry L. Wood |
| IPO Date | 2021-09-15 | CAGR | 0.92% |
| Employees | 756 | Website | www.procept-biorobotics.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
PRCT chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.16B | P/E Ratio | -14.46 |
| Forward P/E | -30.55 | PEG Ratio | — |
| P/S Ratio | 4.68 | P/B Ratio | 4.3 |
| P/CF Ratio | -21.32 | P/FCF Ratio | -18.69 |
| EPS | $-1.83 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 29.26% | Gross Margin | 0.63% |
| Operating Margin | -0.34% | Profit Margin | -0.32% |
| ROE | -0.28% | ROA | -0.21% |
| ROCE | -0.26% | Current Ratio | 6.73 |
| Quick Ratio | 5.51 | Cash Ratio | 3.86 |
| Debt/Equity | 0.15 | Interest Coverage | -30.92 |
| Altman Z Score | 5.37 | Piotroski Score | 3 |